Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study

BACKGROUND: Microdoses of psychedelics (i.e. a sub-hallucinogenic dose taken every third day) can reduce symptoms of depression, anxiety and stress according to anecdotal reports and observational studies. Research with medium to high doses of psilocybin points towards potential underlying mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Marschall, Josephine, Fejer, George, Lempe, Pascal, Prochazkova, Luisa, Kuchar, Martin, Hajkova, Katerina, van Elk, Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801668/
https://www.ncbi.nlm.nih.gov/pubmed/34915762
http://dx.doi.org/10.1177/02698811211050556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801668/
https://www.ncbi.nlm.nih.gov/pubmed/34915762
http://dx.doi.org/10.1177/02698811211050556

Ejemplares similares